# CIMDUO

NDC: 49502-450
Generic name: Lamivudine and Tenofovir Disoproxil Fumarate
Labeler / Manufacturer: Viatris Specialty LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20180625

FDA application: NDA022141

## Active ingredients

- LAMIVUDINE: 300 mg/1
- TENOFOVIR DISOPROXIL FUMARATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49502-450"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49502-450
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a300f04d-118f-4136-aaf3-ddfd00197f86